|
|
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | Trust us. You'll want to read this editorial from Chief Editor Louis Garguilo, who was (gently) reminded he hadn't visited the subject of tech transfer in a while. He answers the questions both sponsors and CDMOs ask to gain the trust to make a tech transfer work for both sides. | |
|
|
|
| Enabling Research Advances Worldwide | Article | Cytiva | Service expectations for life science customers have evolved. Learn how a comprehensive partnership that provides proactive maintenance, expert guidance, and continuous support can be your solution. |
|
|
| Development, Manufacturing Of Vaccines Containing Aluminum Adjuvants | Article | By Jackie Fan, MSc (ENG), PEng, Resilience US, Inc. | Incorporating adjuvants like aluminum salts into vaccines has several benefits, but it's crucial to understand the challenges in developing and manufacturing these formulations to ensure a successful CDMO partnership. |
|
|
|
|
|
| Webinar: Building Quality by Design for Multi-Specific Therapeutic Proteins | This Lonza webinar explores the development of multi-specific biotherapeutics, which offer enhanced efficacy but pose manufacturing challenges. Lonza’s toolbox approach—featuring in silico developability screening, vector design, the GS Gene Expression System®, and immune cell assays—enables early risk assessment of manufacturability and immunosafety. This helps streamline candidate selection and accelerate timelines into clinical development. Click here to learn more. |
|
|
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
